Therapeutics

Top Story

Axim, Ora partner on glaucoma, dry eye clinical trials

March 30, 2017

AXIM Biotechnologies Inc. announced it has retained the services of Ora Inc. to perform the company’s upcoming product development and clinical trials for treating glaucoma and dry eye utilizing cannabinoid-based therapeutics.

Ora will run the clinical programs under the supervision of Robert Ritch, MD, surgeon director emeritus and chief of glaucoma services at New York Eye and Ear Infirmary of Mount Sinai School of Medicine.

Meeting NewsVideo

VIDEO: Débridement - First step in treating herpes simplex keratitis

March 6, 2017
ATLANTA – Here at SECO during a Primary Care Optometry News-sponsored course on therapeutics, Carl Spear, OD, said he treats herpes simplex keratitis by first…
Meeting NewsVideo

VIDEO: Genetic therapies are the future in AMD treatment

March 3, 2017
ATLANTA – Eric Sigler, MD, focused on choroidal retinal degenerations during the Retina Roundup here at SECO. “We found that it’s an exciting time, as…
Blog

BLOG: Can you use phenylephrine eye drops in patients taking antidepressants?

March 1, 2017
Each room in my clinic has a list of medications taped to the wall. It’s basically the only thing on the walls besides the phone number to call during an emergency…
COPE

Diabetic Eye Disease: Screening Strategies and Imaging Devices - Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Video
Meeting News Coverage

VIDEO: Antibiotic resistance increases

February 25, 2016
More »
Featured
SECO

SECO

Video
Meeting News

VIDEO: Débridement - First step in treating herpes simplex keratitis

March 6, 2017
More »

Axim, Ora partner on glaucoma, dry eye clinical trials

March 30, 2017
AXIM Biotechnologies Inc. announced it has retained the services of Ora Inc. to perform the company’s upcoming product development and clinical…

Meeting NewsVideo

VIDEO: Débridement - First step in treating herpes simplex keratitis

March 6, 2017
ATLANTA – Here at SECO during a Primary Care Optometry News-sponsored course on therapeutics, Carl Spear, OD, said he treats herpes simplex…

Meeting NewsVideo

VIDEO: Genetic therapies are the future in AMD treatment

March 3, 2017
ATLANTA – Eric Sigler, MD, focused on choroidal retinal degenerations during the Retina Roundup here at SECO. “We found that it’s…

Blog

BLOG: Can you use phenylephrine eye drops in patients taking antidepressants?

March 1, 2017
Each room in my clinic has a list of medications taped to the wall. It’s basically the only thing on the walls besides the phone number to call…

BLOG: When costly drugs are standard of care

February 10, 2017
Let’s say you’re going to the hardware store to buy a wrench. Naturally, the store sells more than one product that can do the same job…

Nicox to study NCX 470 for lowering IOP

January 31, 2017
Nicox is finalizing the design of a first-in-human trial for NCX 470, its novel nitric oxide donating bimatoprost analog being developed for…

Perspectives on Glaucoma

Fixed combination may improve compliance over unfixed therapy

January 19, 2017
Fixed combination travoprost 0.004%-timolol 0.5% may promote improved adherence compared with separate containers of travoprost 0.004% and timolol…

European Commission grants orphan drug designation to oculopharyngeal muscular dystrophy treatment

January 18, 2017
After a positive recommendation from the European Medicines Agency, the European Commission has granted orphan drug designation to BB-301, an…

Blog

BLOG: ‘Doc, can I take this drug if I have glaucoma?’

January 4, 2017
In the mid-1990s, the FDA relaxed regulations regarding direct-to-consumer pharmaceutical advertising that brought ads for medications from the…

In the Journals

Povidone-iodine promising for bacterial keratitis in developing world

December 30, 2016
Povidone-iodine 1.25% can be considered for the treatment of bacterial keratitis when antibiotic treatment is not practical, according to researchers…

More Headlines »
Advertisement
Advertisement